Drug Trial Radar · NCT05848258
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
164
Actual
Start
May 23, 2023
Primary completion
Dec 8, 2025
Study completion Apr 22, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- Rigel Pharmaceuticals
- First posted
- May 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult participants with active moderately-to-severe rheumatoid arthritis (RA).
Conditions
- Rheumatoid Arthritis
Interventions
LY3871801Drug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 2a: Change from Baseline in Disease Activity Score - high-sensitivity C-reactive protein (DAS28-hsCRP)Time frame: Baseline, Week 12
- Phase 2b: Percentage of Participants Achieving American College of Rheumatology (ACR)50Time frame: Baseline to Week 12
Locations
54 sites in 10 countries. Site status is shown where the registry gives one.
Newport Huntington Medical Group
Huntington Beach, California
Integrity Clinical Research
Doral, Florida
Advanced Clinical Research of Orlando - Ocoee
Ocoee, Florida
Encore Medical Research - Weston
Weston, Florida
Conquest Research
Winter Park, Florida
Willow Rheumatology and Wellness PLLC
Willowbrook, Illinois
Accurate Clinical Research, Inc
Lake Charles, Louisiana
Joseph S. and Diane H. Steinberg Ambulatory Care Center
Brooklyn, New York
Icahn School of Medicine at Mount Sinai
New York, New York
Accellacare - Salisbury
Salisbury, North Carolina
Accurate Clinical Research, Inc
Houston, Texas
Overlake Arthritis and Osteoporosis Center
Bellevue, Washington
CIPREC
Buenos Aires, Argentina
Mautalen Salud e Investigación
Buenos Aires, Argentina
CENUDIAB
Buenos Aires, Argentina
Medicina Reumatológica
San Fernando, Argentina
Instituto de Alta Complejidad San Isidro
San Isidro, Argentina
Medical Plus
Uherské Hradiště, Czechia
CHD Vendee
La Roche-sur-Yon, France
CHU Montpellier Lapeyronie Hospital
Montpellier, France
CHU de Nice
Nice, France
Centre Hospitalier Regional D'Orleans
Orléans, France
Hopitaux Universitaires Paris Centre-Hopital Cochin
Paris, France
Centre Hospitalier Universitaire de Reims - l'Hôpital Maison Blanche
Reims, France
CHU Strasbourg-Hautepierre
Strasbourg, France
Universitaetsklinikum Koeln
Cologne, Germany
HRF II - Hamburger Rheuma Forschungszentrum II MVZ für Rheumatologie und Autoimmunmedizin Hamburg GmbH / -T
Hamburg, Germany
Revita Clinic
Budapest, Hungary
Óbudai Egészségügyi Centrum
Budapest, Hungary
CRU Hungary Kft.
Encs, Hungary
Vásárhelyi Sárkányfű KFT
Hódmezővásárhely, Hungary
Kistarcsai Flor Ferenc Korhaz
Kistarcsa, Hungary
Regia Med Kft
Székesfehérvár, Hungary
Vital Medical Center
Veszprém, Hungary
Avron Hospitals
Ahmedabad, India
Sushruta Multispeciality Hospital & Research Centre
Hubli, India
All India Institute of Medical Sciences (AIIMS) - Nagpur
Nagpur, India
Grant Medical Foundation - Ruby Hall Clinic
Pune, India
Medipoint Hospitals Pvt. Ltd.
Pune, India
Investigacion y Biomedicina de Chihuahua
Chihuahua City, Mexico
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.